Shares of Hims & Hers Health (NYSE: HIMS) plunged nearly 10% in regular trading on Tuesday as investors digested a
4 days ago
Novo Nordisk (NYSE: NVO) said it plans to pursue legal and regulatory action against telehealth provider Hims & Hers Health
1 week ago
UnitedHealth Group shares (NYSE: UNH) plunged after U.S. regulators signaled minimal growth in future Medicare Advantage payments, overshadowing the company’s
3 weeks ago
Shares of 60 Degrees Pharmaceuticals (NASDAQ: SXTP) jumped 152% Thursday to an intraday 52-week high after the company announced a
RAPT Therapeutics stock (NASDAQ: RAPT) surged 63.86% to $57.52 in morning trading after GSK announced plans to acquire the biotech
4 weeks ago
Novo Nordisk shares (NYSE: NVO) surged on Friday after UK regulators approved a higher maximum dose of its blockbuster obesity
Shares of Doximity (NYSE: DOCS) plunged about 22% in pre-market trading on Friday after the company issued weaker-than-expected revenue guidance
9 months ago
UnitedHealth Group (NYSE: UNH) saw its shares tumble over 17% on Tuesday after the company withdrew its full-year 2025 guidance
Exelixis (NASDAQ: EXEL) shares jumped over 6% in pre-market trading on Wednesday after the company reported better-than-expected first-quarter results and
DaVita (NYSE: DVA) reported first-quarter 2025 results that came in slightly ahead of Wall Street estimates, supported by steady treatment
Shares of Novo Nordisk (NYSE: NVO) fell more than 3% in pre-market trading Monday after Eli Lilly’s Zepbound outperformed Wegovy
Hims & Hers Health (NYSE: HIMS) stock surged more than 18% in regular trading on Tuesday after several analysts raised
